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Multi-subunit Cullin–RING E3 ligases often use repeat domain proteins as substrate-specific adaptors.
Structures of these macromolecular assemblies are determined for the F-box-containing leucine-rich repeat
and WD40 repeat families, but not for the suppressor of cytokine signaling (SOCS)-box-containing ankyrin
repeat proteins (ASB1–18), which assemble with Elongins B and C and Cul5. We determined the crystal
structures of the ternary complex of ASB9–Elongin B/C as well as the interacting N-terminal domain of Cul5
and used structural comparisons to establish a model for the complete Cul5-based E3 ligase. The structures
reveal a distinct architecture of the ASB9 complex that positions the ankyrin domain coaxial to the SOCS box–
Elongin B/C complex and perpendicular to other repeat protein complexes. This alternative architecture
appears favorable to present the ankyrin domain substrate-binding site to the E2-ubiquitin, while also
providing spacing suitable for bulky ASB9 substrates, such as the creatine kinases. The presented Cul5
structure also differs from previous models and deviates from other Cullins via a rigid-body rotation between
Cullin repeats. This work highlights the adaptability of repeat domain proteins as scaffolds in substrate
recognition and lays the foundation for future structure–function studies of this important E3 family.
© 2013 The Authors. Published by Elsevier Ltd. Open access under CC BY-NC-ND license.Introduction
Lysine ubiquitylation regulates proteasome-de-
pendent protein degradation, as well as changes in
protein localization and activity [1,2]. Ubiquitin is first
loaded by an E1 ubiquitin-activating enzyme onto an
E2-ubiquitin-conjugating enzyme. E3 ubiquitin li-
gases subsequently recruit the charged E2 as well
as substrate to catalyze the transfer of ubiquitin onto
the ε-amine of a target lysine. Over 600 human E3
ligases are identified, offering a rich variety of
structures to accommodate substrates of varying
shapes and sizes. Among the most complex E3s
are the Cullin–RING E3 ligases, which adopt a
modular architecture that combines separate
substrate-binding and catalytic subunits [3,4]. The
Cullin subunit (Cul1–5 or Cul7) binds specific
substrate-recognition proteins and their adaptors
through its N-terminal domain (NTD), whereas theuthors. Published by Elsevier Ltd. Open access uC-terminal domain (CTD) binds a RING protein
(Rbx1 or Rbx2), which in turn recruits the E2-
ubiquitin conjugate. The substrate and ubiquitin are
brought into juxtaposition for ligation upon neddyla-
tion of the Cullin CTD [5,6].
The best characterized complexes are of the SCF
(Skp1–Cul1–F-box) type, which commonly include
the WD40 repeat or leucine-rich repeat domain, for
which a complete crystal structure is known [7]. In
these E3s, the F-box domain of the substrate-
recognition protein binds the adaptor Skp1 to form
a bipartite interface with Cul1. Similarly, suppressor
of cytokine signaling (SOCS)-box-containing pro-
teins form SCF-like E3 ligases by assembly with the
adaptor Elongin C, its partner Elongin B, and either
Cul2 or Cul5 [8,9]. Although first identified in the
SOCS SH2 family, the SOCS box is now recognized
in over 60 human proteins, including proteins
containing ankyrin repeats, WD40 repeats, SPRYJ. Mol. Biol. (2013) 425, 3166–3177nder CC BY-NC-ND license.
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tumor suppressor protein [10–13].
The ankyrin SOCS box (ASB) family comprising
ASB1–18 represents the largest class of SOCS box
proteins but remains relatively poorly characterized.
ASB family proteins contain an N-terminal ankyrin
repeat domain for substrate recognition and a C-
terminal SOCS box for assembly with Elongin B/C,
Cul5, and Rbx2 [13–15]. ASB2 appears suppressive
for the growth of myeloid leukemia cells [14] and
contributes to hematopoietic differentiation through
the destruction of the mixed-lineage leukemia
protein [16], as well as filamins A and B [17].
Similarly, ASB9 negatively regulates cell growth by
ubiquitylation and destruction of ubiquitous mito-
chondrial creatine kinase [18] and creatine kinase B
[19]. Increased expression of ASB9 correlates with
improved prognosis in colorectal cancer [20]. ASB3
and ASB4 are identified as E3 ligases for tumor
necrosis factor receptor II [21] and insulin receptor
substrate 4 [22], respectively. Finally, zebrafish d-
ASB11 degrades the Notch ligand DeltaA to control
Notch signaling and neurogenesis [23,24].
To date, the only available ASB family structure is
that of the truncated ASB9-2 isoform, which lacks the
SOCS box and E3 activity [25]. To establish how the
ankyrin domain folds stably with the SOCS box tofacilitate E3 function, we determined the crystal
structures of the ternary ASB9–Elongin B/C complex
as well as the first structure of the Cul5 NTD. These
data show that the SOCS box of ASB9 contains an
insertion within its classical three-helix architecture
that contacts the ankyrin repeats of ASB9 to induce a
specific and stable orientation between the two
domains that differs from previous SCF-type struc-
tures. Likewise, current models of the Cul5 subunit
are revised by changes to the Cullin repeat
alignments and internal domain rotations. This
work reveals for the first time the distinct molecular
architecture of the ASB family and further highlights
the structural diversity that helps the Cullin–RING E3
ligases to capture their many important targets.
Results
Structure of the ASB9–Elongin B/C complex
Human ASB proteins were co-purified with Elon-
gins B and C and screened for crystallization to
define the structural basis for their assembly. Viable
crystals were obtained in space group P21221 using
a complex containing residues 35 to 294 of human
ASB9. The structure of the ternary complex wasFig. 1. Structure of the ASB9–
Elongin B/C complex. (a) Ribbon
diagram of the ternary complex
colored by domain. Inset shows
the superposition of the consensus
ankyrin repeats (AR1–6) and the
capping repeat (CR), which precedes
the C-terminal SOCS box (red C-ter-
minus). (b) A molecular surface
representation of the complex iden-
tifies a solvent channel between the
capping repeat and the SOCS box.
The surface is colored by electrostatic
surface potential on a scale between
−10 kT/e (red) and +10 kT/e (blue).
(c) Structure-based sequence
alignment of ankyrin repeats
highlighting residues involved in
SOCS box interaction (pink) and
those that conform to the ankyrin
repeat consensus (cyan) [26,27].
Table 1. Summary of data collection and refinement statistics
ASB9–Elongin B/C Cul5NTDnative Cul5
NTD
SeMet
Data collection
Space group P21221 P212121 P212121
Wavelength (Å) 0.980 0.980 0.980
Unit cell dimensions (Å): a, b, c (α = β = γ = 90°) 102.86, 110.74, 113.41 30.18, 64.50, 197.54 30.11, 64.35, 197.50
Resolution range (Å) 50.47–2.58 33.69–2.05 65.83–2.27
Number of unique reflections 41,297 (5914) 25,290 (3681) 18,727 (2657)
Rmeas (%) 10.6 (83.9) 14.5 (80.9) 12.4 (46.7)
〈I〉/〈σI*〉 10.7 (2.1) 7.4 (2.0) 13.6 (4.4)
Completeness (%) 99.7 (99.7) 99.9 (100.0) 100.0 (99.9)
Multiplicity 6.7 (6.3) 3.8 (3.9) 6.8 (6.8)
Anomalous completeness (%) 99.9 (99.7)
Anomalous multiplicity 3.7 (3.6)
Refinement
Maximum resolution used (Å) 2.58 2.05
Number of reflections 39,120 25,227
R-factor (%) 22.9 19.0
Free R-factor (%) 26.5 22.4
r.m.s.d. bond lengths (Å) 0.014 0.008
r.m.s.d. bond angles (°) 1.520 0.940
PDB accession code 3ZKJ 2WZK
Average B-factor (Å2)
Chain A 59.97 34.37
Chain B 89.76
Chain C 123.24
Chain D 68.45
Chain E 97.14
Chain F 89.11
Waters 58.52 43.97
Numbers in parentheses refer to the highest-resolution shell.
3168 Structure of the Ankyrin SOCS Box Familysolved by molecular replacement and refined at
2.6 Å resolution (Fig. 1a; see Table 1 for data
collection and refinement statistics). Six protein
chains forming two ternary complexes were identi-
fied in the asymmetric unit (Supplementary Informa-
tion, Fig. S1a). The two complexes were essentially
identical except for a subtle shift in the relative
position of the ankyrin domain with respect to the
SOCS box (Supplementary Information, Fig. S1b)
and some poor electron density in parts of Elongin B
(chain C). Both regions were involved in crystal
packing (Supplementary Information, Fig. S1a and
c). Here, we focus our discussion on the ternary
complex formed by chains D–F.
The ASB9–Elongin B/C complex adopts an
elongated structure with overall dimensions of
110 Å × 45 Å × 40 Å (Fig. 1a and b). The ankyrin
repeat domain sits atop the SOCS box and closely
resembles the crescent-shape structures of other
ankyrin proteins, including the ASB9-2 splice variant
that lacks the SOCS box (r.m.s.d. of 1.3 Å over 218
Cα atoms). The consensus ankyrin repeat is a
33-residue motif that folds into a helix–loop–helix–β-
hairpin structure [26,27]. In total, ASB9 contains
seven tandem repeats, including six consensus
repeats and a C-terminal capping repeat (Fig. 1a
and c). The shorter capping repeat (Fig. 1a, inset)
starts with an atypical 310-helix and connects to the
C-terminal SOCS box, which binds Elongin B/C in amanner similar to other SOCS box E3 ligases.
Notably, there is little interaction between the
capping repeat and the SOCS box leaving a
solvent-exposed channel through the ASB9 struc-
ture (Fig. 1b).
Ankyrin domains typically mediate protein–protein
interactions through a binding groove on their
concave inner face, which comprises the inner
shorter α-helices and the β-hairpin regions [26,27].
This surface in ASB9 is also supported as the
substrate-binding site by site-directed mutagenesis
(Fig. 1b) [25]. Significantly for its E3 function, this
surface is stably positioned to face the E2-ubiquitin
moiety similar to the SOCS box structures of SOCS2
[28], SOCS4 [29], Gustavus [30], and VHL [31].
Interactions of the SOCS box
The SOCS box is a conserved three-helix motif
(H1–H3) that facilitates multiple protein–protein
interactions through its BC and Cullin box regions
(Fig. 2a). The ASB9–Elongin B/C structure is the first
to describe how the SOCS box assembles with the
ankyrin repeat substrate-recognition domain. Com-
parison with other SOCS box structures reveals a
three-residue insertion preceding the H2 helix of
ASB9 that extends the SOCS box-ankyrin interface
from repeats 4 to 6 (Fig. 2a). While the shorter inner
helices of the ankyrin domain contribute to the
3169Structure of the Ankyrin SOCS Box Familysubstrate-binding groove (Fig. 1a and b), the outer
helices α8, α10, and α12 contribute to the SOCS box
interaction (Fig. 2b). Of the three SOCS box insertion
residues, Ile272 and Gln273 contact the ankyrin
domain and form hydrophobic interactions with
Ile154 and Ile160 as well as hydrogen bond in-
teractions with Asn151 and Ser189, respectively.
ASB9 assembles with the Elongin B/C complex in
a conserved manner through the amphipathic H1
helix of the SOCS box. The hydrophobic face
includes the strictly conserved residues Leu258
and Cys262, which insert into the deep cleft between
Elongin C loop 5 and H4 (Fig. 3a). Significant
hydrophobic and main-chain hydrogen bond inter-
actions are also made by ASB9 Pro255 and Pro256
to Elongin C H3 (Fig. 3a). The interactions of ElonginFig. 2. SOCS box interactions with the ankyrin repeat
domain. (a) Superposition of the SOCS box domains of
ASB9, SOCS4 (PDB ID: 2IZV) [29], and VHL (PDB ID:
1VCB) [31] reveals a three-residue insertion in ASB9,
which enables the SOCS box residues Ile172 and Gln273
to contact AR4 and AR5. The structure-based sequence
alignment highlights SOCS box residues that contact the
ankyrin domain (cyan) as well as those that bind Elongin C
(yellow). The conserved BC box and Cullin box sequence
motifs are boxed. (b) Side-chain interactions in the
ankyrin–SOCS box interface. Hydrogen bonds are
shown by a green broken line.B are well described [28,31]. The long C-terminal tail
extends from the base of the complex to occupy a
hydrophobic pocket formed between Elongin C H4
and SOCS box helices H1 and H2. Here, the most
significant contacts are made by Elongin B Pro100,
Val102, and Met103 (Fig. 3b).
Structure of the Cul5 NTD
The SOCS box orchestrates the further assembly
of the ASB9–Elongin B/C complex into Cul5-
containing Cullin–RING complexes. Attempts to
co-crystallize the higher-order Cul5 complex were
unsuccessful. Since the structure of the Cul5 CTD
was solved previously together with Rbx1 and
Nedd8 [5], we tried instead to crystallize the missing
N-terminal Cullin repeats. Viable crystals were
obtained in space group P212121 using a construct
(Cul5NTD) comprising residues 1 to 384 of mouse
Cul5 and seven C-terminal residues remaining after
tag cleavage. A molecular replacement solution
could not be identified. Selenomethionine-incorpo-
rated protein crystals were therefore prepared and
the structure was determined at 2.05 Å resolution
using phases calculated from single-wavelength
anomalous diffraction.
Overall, the Cul5NTD adopts an extended stalk-like
structure similar to other Cullin family proteins
(Fig. 4a). The NTD is composed of three consecutive
Cullin repeat domains that are closely matched in
structure (Fig. 4b). As observed for other Cullins, the
five-helix fold is diverged in the first repeat, where the
short H5 helix forms an insertion preceding the final
helix (Fig. 4a). A further eight residues in the H5–H6
loop of the Cul5NTD were not defined by the electron
density. Most significantly, the H5 helix is positioned
seven residues further downstream than predicted
by previous sequence alignments [7,12]. Misalign-
ment potentially arose from a 25-residue insertion in
the Cul1 H2–H3 loop, which is absent in Cul5 and
disordered in the Cul1 structure (Supplementary
Information, Fig. S2) [7]. Comparison of the Cul5NTD
and other Cullin structures reveals significant de-
viations in the relative orientations of the three Cullin
repeat domains (Fig. 4c). Most divergent are the
Cul5 and Cul3 [32,35] structures that differ by a
rotation of 28° between Cullin repeats 1 and 3
(Supplementary Information, Fig. S3). Such changes
may reflect inherent flexibility in the Cullin scaffold
and help to confer the correct geometry in each E3
for efficient ubiquitylation.
Cul5 assembly with ASB9–Elongin B/C
ASB9 contains a Cullin box sequence motif (281-
Leu-Val-Leu-Pro-284; Fig. 2a) [12,13] that deter-
mines Cul5 interaction together with Elongin C
[12,13,18,19]. We established a model for this
assembly by superposition of the Elongin C and
Fig. 3. SOCS box interactions with Elongin B/C. (a) Ribbon diagram of the ASB9–Elongin C interface showing the side-
chain interactions of the BC box. (b) The C-terminal tail of Elongin B binds a hydrophobic pocket in the SOCS box.
3170 Structure of the Ankyrin SOCS Box FamilyCul5NTD subunits onto the Skp1–Cul1 structure
[Protein Data Bank (PDB) ID: 1LDK] [7] and relaxed
interface side chains using ICM-Pro (Fig. 5) [36]. The
complexes center upon the Cullin H2 helix with
additional contact from the short H5 [7]. While Cul1
depends on many tyrosine-mediated hydrogen-
bonding interactions, the Cul5 interface is more
hydrophobic (Fig. 5). In particular, the H2 helix
presents an extended hydrophobic surface com-
posed of Phe41, Phe44, His48, and Leu52. Binding
experiments performed using surface plasmon
resonance revealed a 50-fold loss in affinity for the
mutants Phe41Ala and His48Ala and a complete
loss of binding for Phe44Ala, as well as the
neighboring Elongin C mutant Phe109Ala (Fig. 6).
More peripheral substitutions were better tolerated.
Predicted Cullin box interactions with Cul5 Leu52
were disrupted by the bulky substitution Leu52Tyr,but not by the alanine mutant Leu52Ala (Fig. 6).
Similarly, the Gln113Ala mutation in the Cul5 H5
helix was well tolerated, with no apparent change in
the binding affinity (Fig. 6). All of the mutants were
highly expressed and showed the same elution
profile on gel filtration as the wild-type protein,
suggestive of proper folding.
To extend the model to the complete E3, we
mapped onto the Cul5NTD structure the neddylated
Cul5CTD–Rbx1 complex (PDB ID: 3DQV) [5] using
the full-length Cul1 structure as a template (PDB ID:
1LDK) [7]. An E2-ubiquitin intermediate was modeled
from the RNF4-UbcH5A-ubiquitin structure (PDB ID:
4AP4) [37] and docked onto Rbx1 by the homology
of the RING domains. The final model orientates
the substrate-binding groove of ASB9 towards the
E2-ubiquitin with a distance of 100 Å to the reactive
thioester bond (Fig. 7a). The substrate creatineFig. 4. Structure of the Cul5NTD.
(a) Ribbon diagram of the three
Cullin repeat domains. Secondary-
structure elements are labeled. (b)
Superposition of repeats 1 to 3
shows the conserved Cullin fold.
(c) The five known Cullin struc-
tures [7,32–34] are superimposed
by the second Cullin repeat domain.
Superposition reveals the rigid-
body rotations between domains,
with the largest deviations between
repeats 1 and 2. Further compari-
sons with the Cul5NTD structure are
provided in Supplementary Informa-
tion (Fig. S3).
Fig. 5. Model for Cul5 assembly
with the ASB9–Elongin B/C com-
plex. The ASB9–Elongin B/C and
Cul5NTD structures were aligned to
the Skp1–Cul1 template (PDB ID:
1LDK) [7] by superposition of the
Elongin C and Cul5 subunits with
the homologous Skp1 and Cul1,
respectively. Inset displays side-
chain interactions in the model
(Elongin B is omitted for clarity).
3171Structure of the Ankyrin SOCS Box Familykinase B has a diameter of 45 Å as a monomer but is
known to dimerize, potentially reducing this gap
further. For comparison, similar models were built
for the prototypical SCF-type E3s with leucine-rich
repeat (Fig. 7b) and WD40 repeat domains (Fig. 7c).
Notably, these substrate-recognition domains
adopt a perpendicular position to the ASB9 ankyrin
domain, which further closes the gap to the
E2-ubiquitin (82 Å and 65 Å, respectively). These
distances are likely to be bridged by the remaining
(non-crystallized) substrate regions as well as by
the flexible association of the Rbx1 subunit with the
neddylated Cullin.Discussion
The SOCS box is a highly versatile motif that folds
stably with a wide variety of E3 substrate-recognition
domains. Here, we determined the molecular archi-
tecture of the ASB family, which uses an ankyrin
repeat domain for substrate recognition. Remarkably
for a 40-residue motif, the SOCS box establishes
protein–protein interactions with four distinct do-
mains, including the ankyrin domain, Elongin B,
Elongin C, and Cul5. The ankyrin domain interaction
is facilitated by an H1–H2 loop insertion that forms
the primary adaptation of the ASB family. This
positions the crescent shape of the ankyrin repeat
domain roughly coaxial to the long axis of the
Elongin B/C–SOCS box complex.
To date, Cullin–RING E3 ligase structures have
shown the substrate-recognition domain extending
out from the F-box or SOCS box in an L-shaped
arrangement towards the RING-E2 subunits [3,4].
The structure of the ASB9–Elongin B/C ternary
complex is the first to include the ankyrin domain
and reveals a novel perpendicular packing arrange-
ment. This alternative architecture appears favor-
able to present the substrate-binding site to the
E2-ubiquitin. In addition, this arrangement creates a
suitably wide spacing for large globular substrates,such as the creatine kinases. Whereas ASB proteins
represent the most abundant SOCS box family, the
ankyrin repeat domain is notably absent from the
mammalian F-box class [41]. The Poxvirus F-box
ankyrins, which hijack the mammalian ubiquitin–
proteasome system, are a notable exception [42,43].
It will be interesting to determine whether these pack
similarly to the SCF-type E3s or adopt the perpen-
dicular arrangement of ASB9. The use of repeat
domain proteins in Cullin–RING E3 ligases appears
particularly common, from the Cullin repeats to the
leucine-rich repeat, WD40 repeat, and ankyrin
repeats of the substrate-recognition domain. Such
proteins likely provide a highly advantageous scaf-
fold to evolve a large repertoire of binders, perhaps
explaining their enrichment.
The presented structure of the Cul5NTD comple-
ments previous work on the Cul5CTD and allows a
model to be built for a complete Cul5-based E3
ligase [5]. Unexpectedly, the structure also exposes
deviations to previous homology models, including
rigid-body rotations and a change to the Cullin repeat
sequence alignment. Rigid-body rotations between
Cullin repeats have also been identified in different
crystallized Cul1, Cul3, and Cul4 complexes, sug-
gesting that the Cullin scaffold may also offer some
flexibility to increase the catchment area for sub-
strate and E2 or to provide alternative geometries for
polyubiquitylation [32–34,44,45]. Although we pres-
ent a model for the “monomeric” Cullin–RING E3
ligase complex, higher-order assemblies may also
be possible. For example, non-canonical Cul1–Cul5
complexes are reported for ASB2 [46]. While no
significant crystal contacts are present in the Cul5NTD
structure, some close packing is observed between
neighboring Elongin B subunits, perhaps consistent
with transient assemblies (Supplementary Informa-
tion, Fig. S1c). Finally, dimerization of the RING
domain may play a critical role in the ubiquitin transfer
reaction [37,47,48].
The elucidation of the first structure of an
ankyrin-containing Cullin–RING ligase reveals a
Fig. 6. Characterization of Cul5 binding. The ASB9–Elongin B/C complex was assayed for binding to immobilized GST-Cul5NTD using the Biacore 2000 platform (GE
Healthcare). Wild-type and mutant complexes were analyzed at five different concentrations (2, 1, 0.5, 0.25, and 0.125 μM, black curves). Excellent fits to a 1:1
Langmuir binding model (red curves) were obtained for wild-type Cul5 and the Cul5 mutants Leu52Ala and Gln113Ala. The binding of other mutants was severely
reduced. Kinetic parameters are given below the raw data. The values of the χ2-statistical test indicate that the derived kinetic parameters are in good agreement with
the raw data.
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Fig. 7. Comparison of ankyrin repeat, leucine-rich repeat, and WD40 repeat domains. (a) Structure of the ASB9–
Elongin B/C complex (left) and model for the complete E3 assembly (right). The neddylated Cul5CTD–Rbx1 structure (PDB
ID: 3DQV) [5] was built onto the Cul5NTD by superposition on the Cul1 template (PDB ID: 1LDK) [7]. An E2-ubiquitin
intermediate was modeled from the RNF4-UbcH5A-ubiquitin structure (PDB ID: 4AP4) [37] by superposition of Rbx1 and
RNF4. The final model orients the substrate-binding groove of ASB9 towards the E2-ubiquitin with a distance of 100 Å to
the reactive thioester bond (marked by an asterisk). An outline molecular surface of a monomer of human creatine kinase
B (orange, PDB ID: 3DRB) [38] is shown as a reference for the substrate position based on previous modeling [25].
(b) Comparable structure of the prototypical SCF-type E3 containing Skp1–Skp2–Cks1 bound to the substrate p27Kip1
(PDB ID: 2AST) [39] (left) and model for the complete E3 assembly (right). The orientation shown is the same as the ASB9
complex based on the structural homology between Skp1 and Elongin C. The Skp2 leucine-rich repeat (LRR) domain is
arranged perpendicularly to the ankyrin repeat domain of ASB9. Note the F-box occurs N-terminal to the LRR domain in
Skp2, in contrast to the C-terminal SOCS box of ASB9. The substrate is positioned some 82 Å from the reactive thioester
bond. (c) Structure of the Skp1–TrCP1 complex, which uses a WD40 repeat domain to recruit the substrate β-catenin
(PDB ID: 1P22) [40] (left) and model for the complete E3 assembly (right). The substrate is positioned some 65 Å from the
reactive thioester bond.
3173Structure of the Ankyrin SOCS Box Familynovel architecture for the E3 and further exemplifies
the diversity of substrate recognition. This work
provides a framework for understanding ASB-mediated ubiquitylation, as well as a Cul5 model
to explore the interactions of other SOCS box
families, including HIV Vif.
3174 Structure of the Ankyrin SOCS Box FamilyMaterials and Methods
Plasmids
Human ASB9 (UniProt accession number Q96DX5,
residues 35 to 294) and murine Cullin5 (Cul5NTD; UniProt
accession number Q9D5V5, residues 1–384) were sub-
cloned into the vector pNIC-CTHF, which provides C-
terminal hexahistidine and Flag tags cleavable by tobacco
etch virus protease A [49]. Human Elongin B (UniProt
accession number Q15370) and Elongin C (UniProt
accession number Q15369, residues 17–112) were sub-
cloned into pACYCDUET for co-expression with ASB9, as
described previously [28]. For Biacore studies, a GST-
Cul5NTD construct was prepared in pGEX-4T. Mutants
were constructed using the QuikChange Mutagenesis Kit
(Stratagene) according to the manufacturer's instructions.
All Cullin5 constructs were engineered according to the
split and express strategy [50] to contain the solubilizing
mutations Val341Arg and Leu345Asp.Protein expression and purification
The human ASB9 protein was co-expressed with
Elongin B/C in BL21(DE3) cells using 0.1 mM IPTG for
overnight induction at 18 °C. Harvested cells were
resuspended in binding buffer (50 mM Hepes, pH 7.5,
500 mM NaCl, 5% glycerol, and 30 mM imidazole) and
disrupted by sonication. The ternary complex was purified
by Ni-affinity and size-exclusion chromatography using a
Superdex 200 HiLoad 16/60 column (GE Healthcare).
Tobacco etch virus protease A was used to cleave the C-
terminal tag. Further, Ni-affinity chromatography was used
as a final polishing step to remove any remaining
contaminants. For crystallization, the Cul5NTD protein
was expressed in BL21(DE3)-R3-pRARE cells and puri-
fied similarly. For selenomethionine labeling, Cul5NTD
was expressed in B834(DE3) supplemented with 40 mg/L
L-selenomethionine. For Biacore studies, GST-Cul5NTD was
expressed in BL21(DE3) cells and purified on glutathione-
Sepharose resin in phosphate-buffered saline containing
5 mM DTT and 1 mM PMSF. The protein was eluted in
100 mMTris–HCl, pH 8.0, and 20 mMglutathione buffer and
further purified by size-exclusion chromatography using a
Superdex 200 26/60 column (GE Healthcare) equilibrated in
20 mM Hepes, 150 mM NaCl, and 2 mM DTT. Fractions
were analyzed by SDS-PAGE and the purified protein was
concentrated to 10 mg/mL.Biosensor analysis
The ASB9–Elongin B/C interaction with murine Cul5
was investigated by biosensor analysis using the Biacore
2000 platform (GE Healthcare). Fifteen microliters of
10 μg/mL GST-Cul5NTD was immobilized onto an anti-
GST coated CM5 sensor chip (GE Healthcare) using a flow
rate of 5 μL/min. Wild type and individual point mutants of
Cul5 were each immobilized in this manner to a surface
density of approximately 250 response units. Binding of
the wild-type ASB9–Elongin B/C ternary complex to Cul5
was then analyzed by diluting the protein complex in
Hepes-buffered saline containing 0.01% (v/v) Tween-20and passing it over the chip at 20 μL/min. The complexes
were analyzed at five different concentrations (2, 1, 0.5,
0.25, and 0.125 μM). An ASB9–Elongin B/C complex with
a point mutation in Elongin C (F109A) was analyzed under
identical conditions. The chip was regenerated by the
addition of 10 mM glycine, pH 2.0, after each sample
addition. Data were analyzed using the BIAEVALUATION
software (GE Healthcare) and fitting to a 1:1 Langmuir
binding model.Structure determination of ASB9–Elongin B/C
Crystallization was achieved at 4 °C using the sitting-
drop vapor diffusion method. The ASB9–Elongin B/C
complex buffered in 50 mM Hepes, pH 7.5, 500 mM NaCl,
and 10 mM DTT was concentrated to 40 mg/mL and
crystallized using a precipitant containing 0.20 M Na(ma-
lonate), 0.1 M Bistris (2-[bis(2-hydroxyethyl)amino]-
2-(hydroxymethyl)propane-1,3-diol) propane, pH 6.5,
20% polyethylene glycol 3350, and 10% ethylene glycol.
Viable crystals were obtained from a 300-nL drop when the
protein solution was mixed with the reservoir solution at a
2:1 volume ratio. Crystals were cryo-protected with mother
liquor plus 10% ethylene glycol, prior to vitrification in liquid
nitrogen. Crystals were tested at Diamond Light Source
beamlines I02, I03, and I24, with final data collected at
beamline I02 and processed using the CCP4 suite [51].
The ternary complex crystallized in the orthorhombic
space group P21221 with two molecules in the asymmetric
unit. The structure was solved by molecular replacement
using PHASER [52] and the structures of hASB9-2 (PDB
ID: 3D9H) and Elongin B/C (PDB ID: 2C9W) as search
models. Iterative cycles of restrained refinement and
manual model building were performed using Coot [53]
and PHENIX [54].Structure determination of Cul5NTD
Protein was concentrated to 16 mg/mL buffered in
50 mM Hepes, pH 7.5, 300 mM NaCl, 10 mM DTT,
0.5 mM TCEP, 10 mM L-arginine, and 10 mM L-glutamic
acid. Native crystals were grown at 20 °C in 150-nL sitting
drops mixing 50 nL of protein solution with 100 nL of a
reservoir solution containing 0.1 M Bistris, pH 6.5, 25%
polyethylene glycol 3350, and 0.15 M NH4SO2. Mounted
crystals were cryo-protected with an additional 25%
ethylene glycol. Crystals of the selenomethionine-labeled
protein were grown at 20 °C in 150-nL sitting drops mixing
75 nL of protein solution with 75 nL of reservoir solution
containing 20% Jeffamine ED-2001 reagent pH 7.0, and
0.1 M Hepes, pH 6.8. Crystals were cryo-protected with an
additional 25% ethylene glycol. Diffraction data were
collected at 100 K at Diamond Light Source, beamline
I02 for native Cul5NTD and beamline I03 for the seleno-
methionine-labeled crystal. Data were processed using
MOSFLM [55] and scaled using SCALA from the CCP4
suite [51]. Phases were calculated using selenomethionine
single-wavelength anomalous diffraction data and extend-
ed to the highest resolution with SOLVE [56]. An initial
structural model was built using ARP/wARP [57]. Both
Cul5NTD proteins crystallized in the orthorhombic space
group P212121 with one molecule in the asymmetric unit.
Iterative cycles of restrained refinement and manual model
3175Structure of the Ankyrin SOCS Box Familybuilding were performed using Coot [53], REFMAC5 [58],
and PHENIX [54].
Accession numbers
The atomic coordinates and structure factors have been
deposited in the PDB with the following accession
numbers: PDB ID: 3ZKJ and PDB ID: 2WZK.
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